7.21
price down icon3.33%   -0.30
 
loading
Precedente Chiudi:
$7.51
Aprire:
$7.47
Volume 24 ore:
17,047
Relative Volume:
0.04
Capitalizzazione di mercato:
$81.22M
Reddito:
$3.57M
Utile/perdita netta:
$-7.80M
Rapporto P/E:
-7.4307
EPS:
-0.9703
Flusso di cassa netto:
$-6.56M
1 W Prestazione:
+1.40%
1M Prestazione:
+27.59%
6M Prestazione:
+142.81%
1 anno Prestazione:
+237.67%
Intervallo 1D:
Value
$7.15
$7.47
Intervallo di 1 settimana:
Value
$6.87
$7.97
Portata 52W:
Value
$1.33
$7.97

Neuraxis Inc Stock (NRXS) Company Profile

Name
Nome
Neuraxis Inc
Name
Telefono
(812) 689-0791
Name
Indirizzo
11550 North Meridian Street, Suite 325, Carmel
Name
Dipendente
17
Name
Cinguettio
Name
Prossima data di guadagno
2026-03-19
Name
Ultimi documenti SEC
Name
NRXS's Discussions on Twitter

Compare NRXS vs VRTX, REGN, ALNY, ARGX, INSM

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
NRXS icon
NRXS
Neuraxis Inc
7.26 84.02M 3.57M -7.80M -6.56M -0.9703
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
455.43 115.58B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
756.88 79.23B 14.34B 4.50B 3.77B 41.56
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
330.96 43.59B 3.71B 313.75M 465.38M 2.2571
ARGX icon
ARGX
Argen X Se Adr
697.13 43.26B 4.16B 1.29B 734.26M 19.58
INSM icon
INSM
Insmed Inc
148.76 31.97B 606.42M -1.28B -997.58M -6.403

Neuraxis Inc Borsa (NRXS) Ultime notizie

pulisher
05:41 AM

Insider Trends: Does NeurAxis Inc have pricing power2026 Levels & Technical Confirmation Alerts - baoquankhu1.vn

05:41 AM
pulisher
Mar 25, 2026

Treasury Yields: Should I trade or invest in NeurAxis Inc2026 Pullbacks & Capital Efficiency Focused Ideas - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 24, 2026

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth - TradingView

Mar 24, 2026
pulisher
Mar 24, 2026

NeurAxis Shares Rise After Q4 Results Driven by Robust Revenue Expansion - Bitget

Mar 24, 2026
pulisher
Mar 22, 2026

If You Invested $1,000 in Neuraxis Inc (NRXS) - Stock Titan

Mar 22, 2026
pulisher
Mar 22, 2026

Craig Hallum Increases NeurAxis (NASDAQ:NRXS) Price Target to $13.00 - Defense World

Mar 22, 2026
pulisher
Mar 21, 2026

Dip Buying: Can NeurAxis Inc outperform under higher oil prices2026 Trading Recap & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 21, 2026

Gainers Report: Can NeurAxis Inc expand its profit marginsEarnings Beat & AI Powered Market Entry Ideas - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 20, 2026

Neuraxis, Inc.: Fundamental Analysis and Financial Ratings | NRXS | US64134X2018 - marketscreener.com

Mar 20, 2026
pulisher
Mar 20, 2026

NeurAxis (NASDAQ:NRXS) Given New $13.00 Price Target at Craig Hallum - MarketBeat

Mar 20, 2026
pulisher
Mar 19, 2026

NeurAxis Earnings Call: Reimbursement Wins Drive Next Phase - TipRanks

Mar 19, 2026
pulisher
Mar 19, 2026

Earnings call transcript: NeurAxis Q4 2025 sees revenue growth, stock dips - Investing.com Australia

Mar 19, 2026
pulisher
Mar 19, 2026

NeurAxis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 19, 2026
pulisher
Mar 19, 2026

NeurAxis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 19, 2026
pulisher
Mar 19, 2026

NRXS: FY2025 revenue rose 33% to $3.6M, with improved net loss and expanded market access - TradingView

Mar 19, 2026
pulisher
Mar 19, 2026

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph

Mar 19, 2026
pulisher
Mar 19, 2026

Neuraxis 10-K: $3.57M Revenue, $(7.80)M Net Loss - TradingView

Mar 19, 2026
pulisher
Mar 19, 2026

NeurAxis says its pain-treatment device now reaches 100M insured lives - Stock Titan

Mar 19, 2026
pulisher
Mar 19, 2026

Neuraxis (NRXS) expands IB-Stim GI neuromodulation, RED constipation device and IP moat - Stock Titan

Mar 19, 2026
pulisher
Mar 18, 2026

Levels Update: Should I trade or invest in NeurAxis Inc2026 Top Gainers & Expert Curated Trade Ideas - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 18, 2026

Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Argenx Se (ARGX) and Teladoc (TDOC) - The Globe and Mail

Mar 18, 2026
pulisher
Mar 18, 2026

Aug Ideas: What is the implied volatility of NeurAxis Inc2026 Fed Impact & Reliable Volume Spike Trade Alerts - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 17, 2026

NeurAxis, Inc. Hits New 52-Week High of $7.46, Up 141.44% - Markets Mojo

Mar 17, 2026
pulisher
Mar 17, 2026

Breakout Zone: Is NeurAxis Inc impacted by rising ratesTrade Exit Report & Stock Portfolio Risk Control - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 16, 2026

NeurAxis, Inc. Hits New 52-Week High at USD 7.34 - Markets Mojo

Mar 16, 2026
pulisher
Mar 15, 2026

Neuraxis price target raised to $8 from $7 at Craig-Hallum - MSN

Mar 15, 2026
pulisher
Mar 13, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 13, 2026
pulisher
Mar 13, 2026

NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026 - Sahm

Mar 13, 2026
pulisher
Mar 12, 2026

Medical tech firm NeurAxis schedules March 19 call on 2025 results - Stock Titan

Mar 12, 2026
pulisher
Mar 11, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Mar 11, 2026
pulisher
Mar 10, 2026

NeurAxis (NASDAQ:NRXS) Shares Up 0.7%Still a Buy? - MarketBeat

Mar 10, 2026
pulisher
Mar 07, 2026

NeurAxis, Inc. Hits New 52-Week High of $6.35, Up 98.97% - Markets Mojo

Mar 07, 2026
pulisher
Mar 06, 2026

Volume Recap: Can TTWO expand its profit marginsJuly 2025 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

How FlexShares iBoxx 3 Year Target stock trades in high volatilityMarket Activity Summary & Reliable Price Breakout Signals - Naître et grandir

Mar 06, 2026
pulisher
Mar 06, 2026

Update Recap: Should you avoid OSCR stock right now2025 Macro Impact & Entry Point Confirmation Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Aug Highlights: Can NeurAxis Inc stock outperform in a bear marketJuly 2025 Final Week & Real-Time Chart Breakout Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 05, 2026

Chronic Idiopathic Constipation Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | ABBVIE, Eisai Co, Anji Pharma, Yuhan, Renexxion Ireland - Barchart.com

Mar 05, 2026
pulisher
Mar 03, 2026

AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI

Mar 03, 2026
pulisher
Mar 03, 2026

00152 Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 03, 2026
pulisher
Mar 03, 2026

NeurAxis, Inc. Hits New 52-Week High of $6.30, Up 115.75% - Markets Mojo

Mar 03, 2026
pulisher
Mar 03, 2026

S32 Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 03, 2026
pulisher
Mar 03, 2026

BPCF Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 03, 2026
pulisher
Mar 03, 2026

NRXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Mar 02, 2026

Neuraxis (NRXS) awards 47,569 RSUs to senior executive Miranda - Stock Titan

Mar 02, 2026
pulisher
Feb 28, 2026

P 500Share Buyback & Expert Approved Trade Ideas - mfd.ru

Feb 28, 2026
pulisher
Feb 28, 2026

NRXS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 28, 2026
pulisher
Feb 26, 2026

Director at Neuraxis (NRXS) receives 21,598-share equity grant as compensation - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Neuraxis (NRXS) CEO granted 94,173 RSUs in three-year vesting award - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Director at Neuraxis (NRXS) receives 21,598-share stock grant as compensation - Stock Titan

Feb 26, 2026
pulisher
Feb 25, 2026

SMN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 25, 2026
pulisher
Feb 25, 2026

LINK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 25, 2026

Neuraxis Inc Azioni (NRXS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$26.98
price down icon 0.99%
$47.05
price up icon 3.03%
$52.97
price up icon 3.11%
$88.06
price down icon 0.83%
ONC ONC
$272.99
price down icon 1.11%
$146.63
price up icon 6.51%
Capitalizzazione:     |  Volume (24 ore):